Danielle A. Cunningham, MD
@CunninghamOnc
Followers
1K
Following
12K
Media
67
Statuses
618
#RadOnc Physician @KURadonc ⬅️ @MayoClinic RadOnc Residency ⬅️ @UMKCMedSchool ⬅️ #KCMO | #MedEd Illustrator | DM to collaborate
Rochester, MN
Joined June 2018
RT @PDBrownOnc: Physicians & other overachievers always thinking about next task, not living in moment, WAKE UP or you will miss life.
0
15
0
RT @RonaldChenMD: I recommend standard of care radiation treatment, recommended by NCCN guidelines. @UHC @evicorehc denies preauth. I call….
0
10
0
RT @KrishanJethwa: @PDBrownOnc dropping pearls of wisdom and insight!. A classic Paul Brown teaching for residents that has been ingrained.….
0
6
0
RT @AnnaLaVigneMD: Honored to have “Past Paste” selected for the September issue’s cover @IJROBP @sueyom @jenniferbellon2, thank you! Grate….
0
5
0
RT @RonaldChenMD: Congrats to Dr Akhavan! First R01 for junior faculty physician scientist @KURadonc @KUMedCenter Radiation oncologist doin….
0
4
0
RT @PDBrownOnc: Randomized Trial Vestibular Schwannoma.-No diff outcomes hearing, QOL, equilibrium between SRS or observe arm https://t.co/….
0
23
0
RT @KURadonc: Congratulations Dr. John Einck on being awarded the distinction of ASTRO Fellow (FASTRO)! ASTRO fellows are recognized for th….
0
4
0
RT @PDBrownOnc: Practice Changing Trial BRAF & MEK inhib newly diagnosed Papillary Craniopharyngiomas.· 94% response rate, vast majority du….
nejm.org
Craniopharyngiomas, primary brain tumors of the pituitary–hypothalamic axis, can cause clinically significant sequelae. Treatment with the use of surgery, radiation, or both is often associated wit...
0
25
0
RT @ACROresident: 🎉 #radonc PGY-2 Twitter Orientation Week 🎉.ACRO has even more great resources!. ♠️♥️♣️♦️ACRODecks by @QatKhanMD are a gre….
0
4
0
RT @JamesRandallMD1: Good luck to all RO residents taking boards tomorrow, you got this 👍🏻 many thanks to all the educators who created won….
0
6
0
RT @shanestecklein: Privileged to be part of this work from @SWOG led by @reshmajagsi and @KalinskyKevin. 2° analysis of RxPONDER: ⬇️ LRR i….
jamanetwork.com
This secondary analysis of a clinical trial investigates how often patients with favorable-risk, node-positive breast cancer receive regional nodal irradiation, incidence and predictors of locoregi...
0
11
0
RT @PDBrownOnc: Kudos to Dr. Wijnenga @MartinvdenBent & colleagues for this informative study.This work supports CNS5GBM classification. -….
0
1
0
RT @jaguaranna27: Had a wonderful *pregame* discussion tonight. Yay! Many thanks to @AnnaLaVigneMD, @CunninghamOnc, & Will Sperduto for tak….
0
2
0
RT @MayoRadOnc: Tonight, we celebrate our ⭐️outstanding⭐️ graduating 🎓residents @LindsayMorrisMD @CunninghamOnc @HunterGits. We are so so p….
0
9
0
RT @KrishanJethwa: Congratulations to our graduates! So proud of the brilliant, talented, and compassionate physicians you have become! It….
0
3
0
RT @allisongardaMD: I met @LindsayMorrisMD @HunterGits @CunninghamOnc when they were rotating med students and I was a brand new PGY2. Pro….
0
2
0
RT @PDBrownOnc: Newly diagnosed GBM 12 cycles vs 6 cycles Temozolomide, is more better?.The answer is NO https://t.….
0
31
0
RT @vinaigondi: @PDBrownOnc With compelling evidence supporting either HA-WBRT+memantine or SRS for small cell brain mets, we have reached….
0
6
0
RT @JNCI_Now: In this JNCI CS report, AYA cancer survivors face physical and psychological sequelae decades after treatment completion, wit….
0
4
0
RT @PDBrownOnc: In GBM is there a role for “supramaximal” resection of FLAIR/T2 tumor beyond contrast enhancing tumor?.· RANO resect group….
0
25
0